Susquehanna International Group
VIR icon

Susquehanna International Group’s Vir Biotechnology VIR Stock Holding History

Susquehanna International Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$824K Buy
+92,000
New +$733K ﹤0.01% 8403
2025
Q3 		– Sell
-37,400
Closed -$188K – 14000
2025
Q2 		$188K Sell
37,400
-36,000
-49% -$193K ﹤0.01% 11273
2025
Q1 		$476K Buy
73,400
+500
+0.7% +$4.45K ﹤0.01% 9005
2024
Q4 		$535K Buy
72,900
+48,500
+199% +$383K ﹤0.01% 8507
2024
Q3 		$183K Sell
24,400
-72,800
-75% -$632K ﹤0.01% 10553
2024
Q2 		$865K Sell
97,200
-15,300
-14% -$147K ﹤0.01% 6924
2024
Q1 		$1.14M Buy
112,500
+65,100
+137% +$663K ﹤0.01% 6578
2023
Q4 		$477K Sell
47,400
-3,100
-6% -$28.3K ﹤0.01% 8789
2023
Q3 		$473K Sell
50,500
-149,200
-75% -$2.13M ﹤0.01% 8351
2023
Q2 		$4.9M Buy
199,700
+22,900
+13% +$575K ﹤0.01% 3573
2023
Q1 		$4.11M Buy
176,800
+115,300
+187% +$2.95M ﹤0.01% 3741
2022
Q4 		$1.56M Buy
61,500
+600
+1% +$14.7K ﹤0.01% 5197
2022
Q3 		$1.17M Sell
60,900
-53,600
-47% -$1.36M ﹤0.01% 6225
2022
Q2 		$2.92M Buy
114,500
+23,200
+25% +$542K ﹤0.01% 4130
2022
Q1 		$2.35M Sell
91,300
-91,200
-50% -$2.7M ﹤0.01% 5109
2021
Q4 		$7.64M Buy
182,500
+22,200
+14% +$870K ﹤0.01% 3079
2021
Q3 		$6.98M Sell
160,300
-67,500
-30% -$2.92M ﹤0.01% 3408
2021
Q2 		$10.8M Buy
227,800
+19,400
+9% +$882K ﹤0.01% 2806
2021
Q1 		$10.7M Buy
208,400
+126,800
+155% +$6.83M ﹤0.01% 2670
2020
Q4 		$2.19M Buy
81,600
+28,200
+53% +$917K ﹤0.01% 4910
2020
Q3 		$1.83M Sell
53,400
-71,200
-57% -$3.07M ﹤0.01% 4786
2020
Q2 		$5.11M Buy
124,600
+113,800
+1,054% +$3.82M ﹤0.01% 2980
2020
Q1 		$370K Buy
+10,800
New +$290K ﹤0.01% 7568

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Susquehanna International Group's VIR Position: Q1 2026 in Review

Susquehanna International Group reduced its Vir Biotechnology (VIR) stake by 50% in Q1 2026, selling an estimated $1.55M and leaving 195,561 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #6477.

Susquehanna International Group first reported a position in VIR in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.8M in Q1 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Susquehanna International Group held 195,561 shares of Vir Biotechnology worth $1.75M as of Q1 2026.
  • Susquehanna International Group sold 194,497 Vir Biotechnology shares in Q1 2026, an estimated $1.55M.
  • Vir Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6477 holding.
  • Susquehanna International Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 25 quarters since.
  • Susquehanna International Group's Vir Biotechnology position peaked at $8.8M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.